Business Context and Reporting Period
This Form 6-K is filed by Prana Biotechnology Limited, a foreign private issuer based in South Melbourne, Australia. The report covers the month of March 2008, with the specific filing date of March 14, 2008. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate governance event rather than a financial statement.
Material Changes
The primary material change disclosed in this filing is a Change of Director's Interest. No financial performance changes or operational shifts are detailed in the provided text.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to notify the SEC of the director's interest change.
Key Facts for Investor Verification
- The registrant is Prana Biotechnology Limited, not Altery Therapeutics Ltd as indicated in the request metadata.
- The filing discloses a Change of Director's Interest but does not specify the nature or magnitude of the change in the provided text.
- No financial data is included in this specific Form 6-K.
- The report was signed by Geoffrey Kempler, Executive Chairman.